Versant Capital Management’s Shockwave Medical, Inc. Common Stock SWAV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-7
Closed -$2.28K 2020
2024
Q1
$2.28K Hold
7
﹤0.01% 1307
2023
Q4
$1.33K Buy
7
+3
+75% +$567 ﹤0.01% 1422
2023
Q3
$796 Sell
4
-2
-33% -$473 ﹤0.01% 1596
2023
Q2
$1.71K Buy
+6
New +$1.67K ﹤0.01% 1429
2020
Q1
Sell
-7
Closed 1762
2019
Q4
$0 Buy
+7
New +$259 ﹤0.01% 1635

Other funds holding SWAV

Versant Capital Management's SWAV Position: Q2 2024 in Review

Versant Capital Management sold out of Shockwave Medical, Inc. Common Stock (SWAV) in Q2 2024, closing a stake of 7 shares — an estimated $2.28K sold.

Versant Capital Management first reported a position in SWAV in Q4 2019 and held it in 5 quarters. The position peaked at $2.28K in Q1 2024. 7 funds tracked by Wall St. Rank hold SWAV as of Q2 2024.

  • Versant Capital Management reported no remaining Shockwave Medical, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Versant Capital Management sold 7 Shockwave Medical, Inc. Common Stock shares in Q2 2024, an estimated $2.28K.
  • Versant Capital Management first reported a position in Shockwave Medical, Inc. Common Stock in Q4 2019 and held it in 5 quarters.
  • Versant Capital Management's Shockwave Medical, Inc. Common Stock position peaked at $2.28K in Q1 2024.
  • 7 funds tracked by Wall St. Rank held Shockwave Medical, Inc. Common Stock as of Q2 2024.

Based on Versant Capital Management's 13F filing for Q2 2024, filed 8 Jul 2024.